AbolerIS Pharma

Solid scientific results are the foundation of AbolerIS Pharma and will always remain as the driver of the company’s development activities. Ignacio is a co-founder, senior consultant, and member of the SAB of AbolerIS Pharma. Member of several learned scientific societies, Carole coordinates projects leading to the discovery of several therapeutic targets involved in the pathological responses of autoimmune diseases. Francois-Xavier is a co-founder, past president and board member of AbolerIS Pharma. Tomas has more than 30 years of experience in financial management in both big multinationals and small, local companies covering a broad range of industries. Pascal has around 25 years of experience in leading drug discovery and preclinical development programs and teams at several biotech companies. Experience in young biotech companies to develop the strategic development plan for new medicinal products, meetings with investors, and authorities (EMA, FDA, AFMPS), managing CROs and CMOs. Antoine is a CMC expert bringing more than 20 year’s experience acquired in the pharmaceutical industry in the development, manufacturing, clinical supply and regulatory review (FDA, EMA) of several new drugs entities.